Thierry D. Thomas
Expertise in
7
conditions

Thierry D. Thomas

CHU Gabriel Montpied
Clermont-ferrand, FR 
Expertise in
7
conditions
CHU Gabriel Montpied
Clermont-ferrand, FR 

Overview

Thierry Thomas practices practicing medicine in Clermont-ferrand, France.

Mr. Thomas is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Arthritis, Vertebroplasty, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 165 peer reviewed articles and participating in 9 clinical trials.

Gender

Male

Locations

CHU Gabriel Montpied
Clermont-ferrand, France
Other Locations
153A Gilbert Hall, 2100 SW Campus Way, Corvallis, OR 97331

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Haemophilia and Bone Loss PHILEOS Study
Haemophilia and Bone Loss PHILEOS Study
Enrollment Status: Completed
Publish Date: June 03, 2026
Intervention Type: Biological, Radiation
Study Phase: Not Applicable
Prediction of Adalimumab Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive Spondyloarthritis: Pilot Study
Prediction of Adalimumab Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive Spondyloarthritis: Pilot Study
Enrollment Status: Completed
Publish Date: May 27, 2026
Intervention Type: Drug
Study Phase: Not Applicable
Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: January 20, 2026
Intervention Type: Drug
Study Phase: Phase 4
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Biological Drug Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate and a First Biological Drug
Enrollment Status: Terminated
Publish Date: January 20, 2025
Intervention Type: Biological, Diagnostic test
Study Drug: Blood sample
Study Phase: Phase 4
Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss
Bone Microarchitectural Database Constitution From High Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) Device in Clinical Situation Potentially Associated With Bone Loss
Enrollment Status: Terminated
Publish Date: February 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Biological, Diagnostic test
Study Phase: Phase 4
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
Impact of the Persistence of Inflammation at Doppler Ultrasound Level on the Structural Evolution of Erosion in Rheumatoid Arthritis Treated With Biotherapy
Enrollment Status: Completed
Publish Date: October 29, 2018
Intervention Type: Device
Study Phase: Not Applicable
Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation - A Monocentric Study
Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation - A Monocentric Study
Enrollment Status: Completed
Publish Date: May 31, 2017
Intervention Type: Device
View 8 Less Clinical Trials

165 Total Publications

Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: results from the MAJIK-SFR registry.
Cardiovascular risk assessment using the DAS28-GGT score in rheumatoid arthritis patients initiating JAK inhibitors: results from the MAJIK-SFR registry.
Journal: Joint bone spine
Published: March 31, 2026

Frequently Asked Questions about Thierry D. Thomas

Is Thierry D. Thomas a top-rated expert for Osteoporosis?

MediFind is an objective health platform that identifies experts based on real-world data. Thierry D. Thomas is classified as an Distinguished expert for Osteoporosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Thierry D. Thomas participate in research or clinical trials?

Yes. Thierry D. Thomas has published 165 articles and abstracts on conditions like Osteoporosis. You can view a list of Thierry D. Thomas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Thomas's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile